Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-5-1
pubmed:abstractText
Many tumors with neuroendocrine characteristics express high amounts of somatostatin receptors that enable in vivo imaging with [(111)In-DTPA-D-Phe1]-octreotide. In this study, we have analyzed the feasibility in detecting and characterizing thymic masses by somatostatin receptor scintigraphy (SRS).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0161-5505
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
634-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9544670-Adolescent, pubmed-meshheading:9544670-Adult, pubmed-meshheading:9544670-Aged, pubmed-meshheading:9544670-Carcinoid Tumor, pubmed-meshheading:9544670-Carcinoma, pubmed-meshheading:9544670-Diagnosis, Differential, pubmed-meshheading:9544670-Female, pubmed-meshheading:9544670-Humans, pubmed-meshheading:9544670-Iodine Radioisotopes, pubmed-meshheading:9544670-Magnetic Resonance Imaging, pubmed-meshheading:9544670-Male, pubmed-meshheading:9544670-Middle Aged, pubmed-meshheading:9544670-Octreotide, pubmed-meshheading:9544670-Pentetic Acid, pubmed-meshheading:9544670-Radiopharmaceuticals, pubmed-meshheading:9544670-Thymoma, pubmed-meshheading:9544670-Thymus Hyperplasia, pubmed-meshheading:9544670-Thymus Neoplasms, pubmed-meshheading:9544670-Tomography, Emission-Computed, Single-Photon, pubmed-meshheading:9544670-Tomography, X-Ray Computed
pubmed:year
1998
pubmed:articleTitle
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
pubmed:affiliation
Department of Nuclear Medicine National Cancer Institute, Fondazione G. Pascale, Naples, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't